Curatffe CuraLin Review [study Report] ed Ny onDr Weiss: CuraLin Review Cural Abot t Dr. Dereck Weiss Dr, Decker Weiss, NMD, FASA was the first Naturopathic Cardiologist in the Columbia Hospital system, the Arizona Heart institute, and the Arizona Heart Hospital and became a fellow of the ‘American Society of Angiology. Dr. Weiss later opened the Scottsdale Heart institute, where he helped thousands of patients safely reduce medication, eliminate the need for angioplasty and bypass surgery, and naturally reverse heart disease and many arrhythmias. sg? wfDr Weiss: CuraLin Review Cural The Sample The study was conducted on a sample of 20 patients diagnosed with Type 2 Diabetes, representing the following demographic data: e@ n=20 * Gender: 6 Women (30%), 14 Men (70%) © Average Age: 57.5 (Min: 28, Max 84) Average Starting Hbalc: 8.14 % mmol/mol (Min: 6.8, Max: 10.4) The Test All 20 subjects took Curalin exclusively (with no prescription drugs or other nutraceutical products) for a period of 6 to 8 months. For 12 out of the subjects, Dr. Weiss combined Cura * Paleo/Vegan: 5 (25%) * Paleo: 4 (20%) Paleo/Keto: 2 (10%) «Mediterranean: 1 (5%) No dietary changes were made for the remaining 8 subjects. ‘and the following dietary changes: MEASUREMENTS Subjects had their HbAlc measured prior to beginning the test (MO). MO results were used as a benchmark. Subjects also had their HbAlc tested at: Mi: 3-4 months from MO. M2: 6-8 months from MO. To evaluate Curatin’s impact on subjects’ quality of life, additional attributes were evaluated at MO and M2, including: «Fatigue (self-reported on a scale from “I-Absent” to "10-Very Severe”) [Qualitative] ‘Joint Pain (self-reported on a scale from “I-Absent” to “10-Very Severe’) [Qualitative] ‘* Food Cravings (self-reported on a scale from “I-Absent” to “I0-Very Severe") [Qualitative] ‘* Measured weight [Quantitative]Dr Weiss: CuraLin Review Results Measurement #1 (M1) HbAIc The sample reported the following Hbatc results: 100% of subjects (n=20) saw reductions in HbAIC between MO and MI Average absolute HbAIC reduction was 1.5% mmol/mol (Min: 0.4, Max: 2.3). A Subjects Number Average percentage of HbAle reduction was 18.4% (Min: 48% Max: 25.68%). The sample's average MO HbAlc was 8.1% mmol/mol (Min: 6.8, Max: 10.4). Average MI HbAlc was 6.6% mmol/mol (Min: 5.4%, Max: 8.4%). lute o Re 0-04 05-09 10-14 15-19 20-24 25-29 Absolute Reduction (Semmol/mal) 30-34 35-39 CuralDr Weiss: CuraLin Review Re ion per number of, Een Subjects Over Total 0 0.00% 1 5.00% 10% - 14% 3 18.00% 159% - 19% 6 30.00% 20% - 24% 8 40.00% 25% - 29% 2 10.00% 30% - 34% 0 0.00% 35% - 40% 0 00% Total 20 Subjects Number 0% -4% —S%H-9% 10%- 14% 15% - 19% 20% - 24% 25% - 29% 30% - 34% 35% - 40% re HbALe ReductionDr Weiss: CuraLin Review CuraL Measurement #2 (M2) Hbalc Subjects reported the following HbAlc improvements: ¢ 100% (n=20) of subjects reported continued reductions in HbAlc compared to M1. * Subject’s HbAlc average decreases from 8.1% mmol/mol (Min: 6.8, Max: 10.4) to 5.9% mmol/mol (Min: 5.2%, Max: 7.2%). ‘¢ Subjects’ HbAlc decreased an average of 10.2% from MII to M2. * Subjects reported an average percentage reduction in HbAlc reduction of 27% compared to MO (Min: 15.2%, Max: 38.8%). © The largest individual change between MO and M2 was from 9.8mmol/mol to 6.0mmol/mol, a reduction of 3.8mmol/mol or 38.8%.Dr Weiss: CuraLin Review CuraL HbAlc Absolute Reduction: MI & M2 compared to MO MI M2 Caceres) 0-04 1 8% 0 0.00% 05-09 1 5% 0 0.00% 10-14 7 35% 3 15.00% 8 aon | 6 30.00% 20-24 3 15% 5 25.00% 25-29 0 o% | 2 10.00% 30-34 ° ox | 1 5.00% 35-39 ° 0% 3 15.00% Total 20 100% 20 100.00% Absolute Reduction in HbAle per number of Subjects from MO to M2 6 ° lh. 0-04 05-09 10-14 15-19 20-24 25-29 30-34 35-39 Subjects Number Absolute ReductionDr Weiss: CuraLin Review Cural Relative HbAlc Reduction per number of Subjects (eee Sac 0% - 4% 0 0.00% 5% -9% ° 0.00% 10% - 14% ° 0.00% 15% - 19% 3 16.00% 20% - 24% 4 20.00% 25%-29% 5 25.00% 30% -34% 5 25.00% 35% - 40% 3 15.00%, Total 20 10.00% ‘Subjects Number ath 0%-4% 5% -9% 10% 14% 15% 19% 2O%-24% 25%-20% 30% -34% 95% 40% ‘% Reduction HateDr Weiss: CuraLin Review Cural Fatigue Subjects self-reported their Fatigue on a scale of I-10: © 50% (10) of subjects reported Fatigue at MO. * Sof the 10 subjects who reported Fatigue (90%) reported improvements in Fatigue at M2, with an average Fatigue reduction of 4.5 points compared to MO (Min: 2, Max: 7). eported Fatigue Improvements: 20 1s 09 1 2 3 4 5 6 Fatigue Reduction Subjects Number SDr Weiss: CuraLin Review Cura Food Cravings Subjects self-reported their Food Cravings using a scale of 1-10: ¢ 90% (18) of subjects reported Food Cravings at MO (Min: 6, Max: 10) * 11 (61%) of the subjects who reported food cravings at MO (n=18) reported a reduction in Food Cravings at M2. * Subjects reported an average reduction of 3.3 points between MO and M2 (Min: 0, Max: 9). The Il subjects that reported improvements in food cravings between MO and M2 reported an average reduction of 5.45 points from MO (Min: 2, Max: 9). ° 3 4 5 6 1 8 9 Food Cravings Reduction Subjects Number cont ; 10Dr Weiss: CuraLin Review CuraL Joint Pain Subjects self-reported their Joint Pain using a scale of I-10: * 45% (9) of subjects reported joint pain at MO. + 100% of subjects reporting Joint Pain at MO reported improvements in Joint Pain between MO and M2. ‘© The 9 subjects that reported improvements in Joint Pain reported an average Joint Max: 6). Pain reduction of 4 points from MO (Min: Reported Joint Pains Improvements: MO-M2 a Subjects Number i 1 ry 3 4 5 6 7 Joint Pains Reduction "Dr Weiss: CuraLin Review CuraL Weight ‘Subjects self-reported their Weight at MO and M2: © 80% (16) of subjects reported changes in weight between MO and M2. ‘* 100% of the weight changes represented Weight Loss (n=16). ‘¢ The sample (n=20) reported an average Weight Loss of 121 Ibs (5.5 kg) fromm MO-M2 (Min: 0, Max: 48Ibs (21.8Kg)). ‘The 16 subjects that reported Weight Loss, reported an average weight loss of 15.22Ibs (6.9kg) between MO and M2 (Min: 4ibss (1.8Kg), Max: 48s (21.8Kg)). Reported Weight Loss: MO-M2_ 6 Subjects Number 1-4 5-9 10-18 15-19 20-28 25-29 30-34 35-39 04s 5-49 ‘Weight Los lbs)Dr Weiss: CuraLin Review CuraL Dr. W “In tracking my first 20 patients that | have used Curalin with | have found remarkable blood eiss's Comments sugar improvements that | have not seen with any other natural product, or metformin. Within 90 days my more severe cases have dropped over a full point on their hemoglobin Alc and most of my milder cases have come under complete control.” “Ihave not seen any adverse effects other than a drop in blood pressure causing patients to decrease their blood pressure medication” “some of my patient's blood sugar recovered without changing their diet” “Per this data, | have never seen any product behave more effectively than Curatin* “Per this data, we may have found the first true alternative to pharmaceutical intervention for type 2 diabetes.” eY ‘af ot e Y 13